COMMITTED TO MAKING A DIFFERENCE

Novavax, Inc. is a global biotechnology company committed to helping address serious infectious disease globally through the discovery, development, and delivery of innovative vaccines to patients around the world.

Our mission

We never rest in our quest to protect the health of people everywhere.

Novavax is here to make a difference. We're a biotech company focused solely on developing life-saving vaccines to fight infectious diseases.

What sets us apart? Solid science tested by decades of research. Vaccines developed from trusted technology that are both safe and efficacious. 

And a global network that will help ensure our vaccines reach everyone who needs them. 

Novavax AB

Novavax AB is located in Uppsala, Sweden. This facility is responsible for research, development and production of our saponin-based adjuvants. Our Matrix-MTM is used in multiple vaccine candidates to enhance the immune response and stimulate high levels of neutralizing antibodies. 

Novavax AB Location

Select local leaders

Magnus Sävenhed
Magnus Sävenhed
Managing Director,
Novavax AB
Markus Salmela
Markus Salmela
Senior Director Operations,
Novavax AB
Martin Holkedahl
Martin Holkedahl
Senior Director Quality,
Novavax AB
Otti Bengtsson Gref
Otti Bengtsson Gref
Senior Director Research and Product Development,
Novavax AB
Erik Jakubek
Erik Jakubek
Director IT and Security,
Novavax AB
Lena Rönnlund
Lena Rönnlund
Director Finance,
Novavax AB
Magnus Backholm
Magnus Backholm
Director Technical Support and EHS,
Novavax AB
Jenny Reimer
Jenny Reimer
Director Alliance and Project Management,
Novavax AB
Jonas Karlson
Jonas Karlson
Director HR and Administration,
Novavax AB
Evonne Strand
Evonne Strand
Global Regulatory Affairs Manager,
Novavax AB
Alvar Paz
Alvar Paz
General Manager,
Commercial Strategy,
Europe
How to contact Novavax
General inquiries

+46 (0)18-843 62 01
09:00 - 17:00
Monday - Friday

More information is available on our global website, novavax.com.

Our location: 
Kungsgatan 109, 753 18 Uppsala, Sweden

Media contact

Email: 
Phone: (+41 44 553 05 71

Investor contact

To contact a member of the investor relations team, click on the "Contact us" button below.